At the UK–Korea Neuroscience Symposium (12–13 August, London, UK), we had the fantastic opportunity of…
Search Results: sfn (70)
A woman genetically predisposed to have early-onset autosomal dominant Alzheimer’s disease at the age of 40 did not display symptoms until her 70s. This has been linked to the presence of a rare gene variant termed APOE3ch.
New research presented at SfN Neuroscience 2019 outlines some of the exciting developments and important limitations in the use of brain organoids as models for human cortical development.
Three studies presented at SfN Neuroscience 2019 have shed light on the complex interplay between microglia in neuroinflammation and disease pathology in mice.
Three studies presented at SfN Neuroscience 2019 reveal advancements in autism research that could improve intervention and treatment.
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.
Abstracts presented at SfN Neuroscience 2019 provide insight into how gene therapy advancements could be used treat diseases such as Parkinson’s and Alzheimer’s in the future.
SfN19: Metabolic disturbances in the brain may exacerbate and forewarn Alzheimer’s pathology in mice
Abstracts presented at SfN Neuroscience 2019 have revealed that metabolic disturbances in the brain could exacerbate and forewarn Alzheimer’s pathology in mice.
New research suggests that exosomes could play an important role in brain circuits, cell signaling and cell communication.
At the BNA Festival of Neuroscience, we had the pleasure of speaking with Barry Everitt about his talk on ‘Addiction: a compulsive interplay between drugs, cues and habits’.